Inflammatory mediators such as interleukin-6 (IL-6) [19], tumor necrosis factor-α (TNF-α) [15] and lipid peroxidation product malondialdehyde (MDA) [16, 20] played an important role in the initiation of inflammatory responses in HSP. The gene discussed is IL6; the disease is hereditary spastic paraplegia.